| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Growth Officer
1 company
Glavine Paul serves as a Chief Growth Officer at HELP. Across recent SEC filings that breaks down to 4 buys and 0 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | HELP Cybin D/b/a Helus Pharma | Chief Growth Officer | Buy | 100,000 | $12.47 | $1,247,190.00 | +2.4% | |
| Sep 8, 2026 | HELP Cybin D/b/a Helus Pharma | Chief Growth Officer | Buy | 100,000 | $12.47 | $1,247,190.00 | +2.4% | |
| Sep 3, 2026 | HELP Cybin D/b/a Helus Pharma | Chief Growth Officer | Buy | 100,000 | $11.78 | $1,178,280.00 | +2.5% | |
| Aug 31, 2026 | HELP Cybin D/b/a Helus Pharma | Chief Growth Officer | Buy | 90,000 | $11.59 | $1,042,677.00 | +2.3% |